Why the study?
Does a novel transcatheter bicaval valve with an innovative stent design reduce Reynolds shear stress compared to generic stent designs in the treatment of tricuspid regurgitation?
Does a novel transcatheter bicaval valve with an innovative stent design reduce Reynolds shear stress compared to generic stent designs in the treatment of tricuspid regurgitation?
An innovative stent design for transcatheter bicaval valves reduces Reynolds shear stress, potentially lowering the risk of platelet activation in the treatment of tricuspid regurgitation.
Answers are grounded in this paper and cite their sources.
Suggests a potential mechanical advantage for reducing platelet activation in tricuspid regurgitation; leaves open whether.
The concept of heterotopic implantation of transcatheter tricuspid valve is new and has shown promising results thus far. While the Reynolds shear stress values measured in the vicinity of this valve are relatively low, the values at some time points are higher than the threshold of platelet activation. Hence, in this study, we aim to reduce these values with an innovative stent design. It was shown that the Reynolds shear stress values measured were lower than those of valves made of generic stent design and the maximum Reynolds shear stress values in the vicinity of the valves was very low (∼10 dynes/cm2). The results also depicted the interesting flow phenomenon of this non‐physiological treatment approach. Thus, this study has shown that bicaval valves could potentially be considered as a minimally invasive option to treat tricuspid regurgitation and valve design improvements could reduce the flow disturbances that were observed.
No takes yet. Share an insight, caveat, or question.
Ismail et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: